Physician profile
Clark E Fielden
NPI 1457339285
$2,063.18
in general payments reported to CMS, 2019-2025
16 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $132 · 2021: $242 · 2022: $403 · 2023: $398 · 2024: $412 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,084 · Entertainment: $76.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.80 |
| Entertainment | $76.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $477.28 | 2022-2025 | Infuse, Miebo, Biotrue One Day |
| Sun Pharmaceutical Industries INC. | $458.40 | 2021-2025 | Cequa |
| Alcon Vision LLC | $323.61 | 2019-2025 | Dailies Total1, Total30, Rocklatan |
| Johnson & Johnson Vision Care, INC. | $177.93 | 2020-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $121.77 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $83.65 | 2024-2025 | Xdemvy |
| Optos, INC. | $76.93 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Glaukos Corporation | $70.18 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Johnson & Johnson Surgical Vision, INC. | $65.08 | 2020-2021 | |
| Coopervision INC. | $57.80 | 2019-2024 | Myday Contact Lens |
| Kala Pharmaceuticals, INC. | $36.07 | 2021-2022 | |
| Biotissue Holdings INC. | $35.67 | 2022-2023 | |
| Rxsight INC | $28.11 | 2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Dompe US, INC. | $18.76 | 2024 | Oxervate |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $12.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clark Fielden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.